Hints and tips:
Related Special Reports
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
...Britain after Brexit is edited by Gordon Smith. Premium subscribers can sign up here to have it delivered straight to their inbox every Thursday afternoon....
...“The drive to renegotiate agreements is not unique to Novavax but they are more pressed against a wall because of their difficult financial situation,” said Brendan Smith, analyst at Cowen, an investment...
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...Smith has looked into one of the problems that has taken the shine off Paxlovid....
...The show’s editor is Jess Smith. Additional help by Peter Barber and Gavin Kallmann. The show’s theme song is by Metaphor Music. Topher Forhecz is the FT’s executive producer....
...It’s all very colourful though. 5) Fern Labs Inc ($1mn for 5 per cent stake) There’s a company called Fern Labs Inc based at 280 Smith St, Farmingdale, NY 11735, United States, roughly in the middle of...
...Its share price has languished since chief executive Alan Jope took over in 2019, and top-10 investor Terry Smith this week attacked the company as “labouring under the weight of a management which is obsessed...
...Smith said: “All companies want to hold on to their innovation....
...Attendees include Disney’s chief executive Bob Chapek, Microsoft’s president Brad Smith and Business Roundtable head Joshua Bolten....
...FedEx, which has shipped about half of vaccine doses in the US, is struggling with record volumes, though Richard Smith, the company’s regional president for the Americas, told the FT the jab deliveries...
...Hempton, known for his bets against companies such as Valeant Pharmaceuticals and Wirecard, raised concerns about the level of insurance extended to Greensill by IAG, calling it “potentially a solvency risk...
FT tracker shows rapid growth in doses administered around world — but warnings come of long road ahead
...He spotted the value in an unloved unit of just 25 people still working on inoculations, led by Gale Smith, now Novavax’s vice-president of vaccine development....
...Germany’s BioNTech and US pharmaceutical company Pfizer said doses of the vaccine would be delivered to the UK in the coming days after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)...
...Fast-forward to the present and DD’s Kaye Wiggins and Robert Smith have unearthed some new details in this just published piece....
..., technology and pharmaceuticals, writes Kana Inagaki....
...The 89-character warning helped to usher in a period during which the threat of a root-and-branch reform of drug pricing has hung over the US pharmaceuticals industry....
...In April last year, BlackRock refused to back the board of German pharmaceutical group Bayer at the company’s annual meeting, in a largely symbolic protest over its handling of a merger with pesticides-maker...
...marks ‘strong year’ with record revenues, profits and assets (FT) Sirius investors give wary backing to Anglo American takeover (FT) Due Diligence is written by Arash Massoudi, Kaye Wiggins and Robert Smith...
...White & Case has hired Will Smith as a partner in the firm’s global tax practice in London. Smith joins from Sidley Austin....
...In 2017 Evenstad sold the largest part of Upsher-Smith, the generics business, to Sawai Pharmaceutical for $1.05bn in early 2017 and it seems the equity didn't fall far from the family tree....
...Rounding out the top three is pharmaceutical group AbbVie, which generated roughly $311m in fees for its investment bankers last year. Much of that was tied to its $84bn takeover of Allergan....
...Analysts have suggested doctors may have little incentive to abandon the treatment they have always used, but Dr Kimberly Smith, ViiV’s head of global research and medical strategy, said it would take time...
International Edition